AI-generated from publicly available materials.Syneos Health has unveiled its largest Global Capability Centre in Asia, located in Hyderabad, aimed at advancing AI-driven healthcare solutions.
This new facility, situated in Gachibowli, is a significant addition to Syneos Health's global operations, emphasizing the integration of artificial intelligence, data engineering, and technology within clinical development and patient safety. The Hyderabad hub is positioned to enhance the company's offerings across the entire drug development lifecycle, providing tailored AI solutions that address various aspects of biopharmaceutical workflows.
The centre focuses on developing innovative applications such as AI-assisted clinical protocol design and predictive analytics for site selection, as well as automating pharmacovigilance processes. By leveraging advanced technologies, the hub aims to create tools that streamline operations and improve patient safety in regulated environments. Additionally, the Hyderabad team is exploring generative AI applications to facilitate decision-making within clinical and commercial contexts.
This strategic move not only reinforces Syneos Health's commitment to AI-led innovation in healthcare but also positions Hyderabad as a vital center for attracting specialized talent in this rapidly evolving field. As the demand for AI solutions in biopharma continues to grow, this hub could play a crucial role in shaping the future of healthcare delivery.